Cardinal's pharmaceutical and specialty solutions segment distributes branded, generic, and specialty drugs and over-the-counter healthcare and consumer products. Cardinal plays a central role in the ...

From the pandemic to natural disasters, the fragility of our supply chain is very real. In 2025, healthcare leaders should ...

Organizational leaders in every industry around the world are evaluating ways AI can unlock opportunities, drive pragmatic ...

Sirona Medical, a leader in cloud-native radiology workflow solutions, announced the appointment of Ken Kaufman as Chief Executive Officer. Kaufman is a seasoned executive and business builder with a ...

In a report released yesterday, Elizabeth Anderson CFA from Evercore ISI maintained a Buy rating on McKesson (MCK – Research Report), with a ...

At Fierce Healthcare, we keep track of all the venture capital being funneled into the health tech and digital health ...

McKesson (MCK) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term. Over the ...

McKesson MCK has started 2025 on a positive note, with the stock climbing 4% so far in January as investors remain optimistic ...

McKesson's stock appears undervalued, trading at 18 times forward earnings and free cash flow. See why MCK is a Hold.

Evercore ISI analyst Elizabeth Anderson CFA reiterated a Buy rating on McKesson (MCK – Research Report) yesterday and set a price target of ...